
16 Jul 2026
Weight Loss Treatment Without Needles: What the Wegovy Pill Means for People Who Hate Injections
All medical information is reviewed by our clinical partners at MedicOnline.
Dr. Jahan Khan, CMO @ MedicOnline
IMC 409788
There are people who would benefit enormously from medical weight loss treatment but have never started because of a needle. Not because they did not qualify, not because they could not afford it, not because they did not want to - but because the idea of injecting themselves once a week, indefinitely, was a barrier they could not get past.
If that is you, nobody should dismiss it. Needle anxiety is not squeamishness or a lack of commitment. Trypanophobia (the clinical term for needle phobia) affects an estimated 20-25% of adults to some degree, and for a meaningful proportion of those people it is severe enough to avoid medical procedures entirely. When the only weight loss medications available are injectable, that anxiety becomes a genuine barrier to treatment.
The landscape is changing. The European Commission approved the Wegovy pill on 15 July 2026 for weight management across the EU. A daily tablet that delivers the same clinical results as the weekly injection, with no needles involved at all. For people whose needle anxiety has been the only thing standing between them and treatment, this is a meaningful development.
But the pill is not in Irish pharmacies yet. So the question for right now is: what do you do in the meantime?
The Pill Is Approved, but Not Yet Available in Ireland
EU marketing authorisation means the Wegovy pill can be sold in any EU member state, including Ireland. However, Novo Nordisk still needs to complete the distribution and supply chain setup before Irish pharmacies can dispense it. Based on the company's stated plan to launch in EU markets in the second half of 2026, a realistic window for Irish availability is late 2026 to early 2027.
Until then, the treatment options available in Ireland for medical weight management are injectable: Mounjaro (tirzepatide, once weekly) and Wegovy (semaglutide, once weekly). Both use auto-injector pens with very fine needles, but they are still injections.
For more on the pill's timeline and how it compares to the injection, see our post on when the Wegovy pill will be available in Ireland.
What If You Cannot Wait?
If you have a BMI of 30 or above (or 27 with a weight-related health condition) and your doctor recommends treatment, waiting several months for the pill while an equally effective injection is available today is rarely the best decision for your health. Every month of untreated obesity carries its own risks - to your cardiovascular system, your joints, your metabolic health, and your quality of life.
That does not mean your anxiety is not real. It means there are ways to manage it that might allow you to start treatment now rather than putting your health on hold.
Strategies That Help with Injection Anxiety
These come from patients who have been through it and from our clinical team's experience working with people who were genuinely anxious about their first injection.
Understanding what the pen actually involves: The Mounjaro KwikPen and the Wegovy FlexTouch pen are both auto-injectors, which means you never see the needle, never handle it, and never manually push anything through your skin. You press the pen flat against your skin, click a button, hold for ten seconds, and lift it off. The needle is 4mm long - shorter than the width of a pencil eraser - and retracts automatically into the pen body after use. Most patients say they barely feel it, and many say they feel nothing at all after the first couple of weeks.
Choosing the right injection site: The abdomen tends to be the least sensitive site for most people because there is more subcutaneous tissue between the skin and the underlying structures. If you are particularly anxious, starting with the abdomen and moving to other sites once you are comfortable can help build confidence gradually.
Letting the pen warm up fully: Cold medication can cause a stinging sensation that makes the experience worse than it needs to be. Taking the pen out of the fridge a full 30 minutes before injecting - rather than rushing to get it over with - genuinely reduces discomfort.
Having someone with you for the first one: Whether it is a partner, a friend, or a family member, having another person present for your first injection can make it feel less daunting. Some patients prefer to have the other person actually press the button for them the first time, and then take over themselves from the second injection onwards.
Not watching: You do not need to look at the pen while it is against your skin. Many patients look away, focus on their breathing, or put on a podcast, and the ten seconds pass before they have really thought about it.
Reframing the frequency: One injection per week, taking ten seconds, is 520 seconds per year. Under nine minutes total across an entire year of treatment. When you put it in those terms, the actual time spent injecting is negligible compared to the other things you do for your health every day.
If needle anxiety has been the thing holding you back, our clinical team understands. You can check your eligibility and discuss your concerns with a doctor who can help you decide what is right for you.
When the Pill Arrives: What to Know
Once the Wegovy pill reaches Irish pharmacies, it will offer a genuine needle-free alternative for eligible patients. The clinical results from the OASIS trial programme show weight loss comparable to the injection (approximately 16-17% of body weight over 68 weeks), with a similar side-effect profile.
The trade-off is a daily commitment rather than a weekly one. The pill needs to be taken every morning on an empty stomach with a small amount of water, followed by a 30-minute wait before eating or drinking anything else. For some people that will feel more manageable than an injection; for others, the once-weekly injection might actually be simpler once the initial anxiety is overcome.
At Bua, we will offer the Wegovy pill alongside injectable Mounjaro and Wegovy as soon as it is available through Irish pharmacies. Our clinical team will help you decide which format suits your situation, your preferences, and your health profile.
A Note On What Is Not a Real Alternative
If you have been searching for needle-free weight loss options and come across semaglutide drops, patches, gummies, or sublingual tablets being sold online, these are not legitimate products. The HPRA seized over 48,000 fake GLP-1 products in Ireland in 2025, many of which were marketed as needle-free alternatives. Testing confirmed that the patches contained no semaglutide at all.
The only authorised oral semaglutide for weight management is the Wegovy pill (25mg), which has just received EU approval and is not yet available in Ireland. Anything else claiming to be a needle-free GLP-1 for weight loss should be avoided.
The Right Decision Is the One You Make With Your Doctor
Whether you decide to start injectable treatment now, wait for the pill, or explore other approaches to weight management, that decision should be made with a doctor who understands both your medical situation and your concerns. Needle anxiety is a legitimate factor in that conversation, not something to be embarrassed about or dismissed.
Treatment is always subject to clinical assessment by an IMC-registered doctor based on your full health profile, and a prescription is never guaranteed. If you are found not to be eligible, Bua provides a full refund of the programme fee.
Related Reading
- The Wegovy pill in Ireland: when will it be available?
- Do I qualify for Wegovy in Ireland?
- Wegovy vs Mounjaro in Ireland: which is right for you?
- What weight loss injections are available in Ireland?
- How to Inject Mounjaro: A Step-by-Step Guide for Irish Patients
- Oral Wegovy vs Injectable Wegovy: Which Should You Choose?
- The Wegovy Pill Has Been Approved in Europe: What This Means for Irish Patients
References
- Novo Nordisk. European Commission approves Wegovy pill for weight management in the EU. 15 July 2026.
- Wharton S, et al. Oral Semaglutide at a Dose of 25mg in Adults with Overweight or Obesity (OASIS 4). NEJM. 2025;393(11):1077-1087.
- HPRA. Over 750,000 units of illegal medicines detained in 2025. March 2026.
- McLenon, J., Rogers, M.A.M. The fear of needles: a systematic review and meta-analysis. Journal of Advanced Nursing. 2019;75(1):30-42.
- European Medicines Agency. Wegovy: Summary of Product Characteristics.
Related Blogs

Who Qualifies for Mounjaro in Ireland?
An overview of the clinical criteria, safety checks, and medical assessment process doctors use to decide who is eligible for Mounjaro® (tirzepatide) in Ireland.
Read
What weight loss injections are available in Ireland?
A clear breakdown of the three main medical treatments for weight management in Ireland in 2025 and 2026
Read
Who can't take Mounjaro? Understanding the contraindications
A comprehensive guide to the absolute contraindications and other cautions that determine who cannot safely take Mounjaro® (tirzepatide) in Ireland.
Read
Who Qualifies for Mounjaro in Ireland?
An overview of the clinical criteria, safety checks, and medical assessment process doctors use to decide who is eligible for Mounjaro® (tirzepatide) in Ireland.

What weight loss injections are available in Ireland?
A clear breakdown of the three main medical treatments for weight management in Ireland in 2025 and 2026

Who can't take Mounjaro? Understanding the contraindications
A comprehensive guide to the absolute contraindications and other cautions that determine who cannot safely take Mounjaro® (tirzepatide) in Ireland.
